Abstract: HLA-DP polymorphisms promoting HBV clearance were associated with a lower prevalence of mutations increasing
HCC risk (
C1653T,
T1674C/G,
A1846T,
G1896A and
pre-S2 mutations and
pre-S deletion in genotype C) and a higher prevalence of mutations decreasing
HCC risk (
G1652A,
T1673C,
T1674C,
G1719T,
G1730C, and
G1799C in genotype B and
A1727T in genotype C).